Medical School · Year 2 · Renal · includes a quiz and discussion video

Lecture 2: Glomerular Filtration and Renal Blood Flow

Unit 2.1: Renal System

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the determinants of glomerular filtration rate (GFR)
2. Explain the Starling forces governing filtration
3. Describe the regulation of renal blood flow and GFR
4. Explain the concepts of clearance and its use to measure GFR
5. Describe autoregulation of renal blood flow
6. Apply GFR concepts to clinical assessment of kidney function

Overview of Renal Function

The kidneys serve multiple essential functions that extend far beyond simple waste excretion. They eliminate metabolic waste products including urea from protein catabolism and creatinine from muscle metabolism, while simultaneously regulating fluid volume, electrolyte concentrations, and acid-base balance with remarkable precision. The kidneys also function as endocrine organs, secreting renin to regulate blood pressure, erythropoietin to stimulate red blood cell production, and converting 25-hydroxyvitamin D to its active 1,25-dihydroxyvitamin D form. Additionally, renal gluconeogenesis contributes significantly to glucose homeostasis during fasting states.

These diverse functions are accomplished through three fundamental processes occurring along the nephron. Filtration takes place at the glomerulus, where plasma is filtered across the glomerular capillaries into Bowman's space. Reabsorption occurs throughout the tubular system, returning useful substances from the tubular fluid back to the peritubular capillaries. Secretion represents the transfer of specific substances from peritubular blood into the tubular lumen. The final urine composition reflects the sum of these processes, expressed by the equation: Excretion equals Filtration minus Reabsorption plus Secretion.

The magnitude of glomerular filtration is extraordinarily large. The glomerular filtration rate (GFR) approximates 180 liters per day, equivalent to roughly 125 milliliters per minute. This means the entire plasma volume is filtered approximately 60 times daily. Yet only about 1.5 liters of urine is excreted each day, indicating that greater than 99 percent of the filtrate is reabsorbed along the nephron. This seemingly inefficient design allows the kidney to precisely regulate the composition of body fluids by adjusting reabsorption and secretion rates.

<image>Panel A: Stylized nephron with glomerulus at top demonstrating filtration via blue arrows from afferent arteriole through glomerular capillaries into Bowman's space. Panel B: Tubular segment showing green arrows from lumen toward peritubular capillaries representing reabsorption, and orange arrows from capillaries into lumen representing secretion. Panel C: Excretion equation (Excretion = Filtration - Reabsorption + Secretion) with color-coded terms matching the arrow colors. Panel D: Numerical values showing filtered load (180 L/day), reabsorbed volume (~178.5 L), and final urine output (~1.5 L).</image>

Renal Blood Flow

The kidneys receive an extraordinarily generous blood supply relative to their size. Renal blood flow approximates 1200 milliliters per minute, representing 20 to 25 percent of cardiac output despite the kidneys comprising less than 1 percent of body mass. This high flow rate ensures adequate plasma delivery for filtration. When accounting for the cellular components of blood, renal plasma flow (RPF) measures approximately 600 to 700 milliliters per minute, calculated as renal blood flow multiplied by one minus the hematocrit. For a typical hematocrit of 0.45, RPF equals 1200 times 0.55, yielding approximately 660 milliliters per minute.

The distribution of blood flow within the kidney is highly nonuniform and purposefully designed. The cortex receives approximately 90 percent of total renal blood flow, consistent with its role as the primary site of glomerular filtration. In contrast, the medulla receives only about 10 percent of blood flow, and this relatively low perfusion is essential for maintaining the osmotic gradient that enables urine concentration. Higher medullary blood flow would wash out the carefully established hyperosmotic interstitium.

The filtration fraction represents the proportion of plasma filtered at the glomerulus, calculated as GFR divided by RPF. Under normal conditions, the filtration fraction approximates 20 percent or 0.20, meaning that roughly one-fifth of the plasma passing through the kidney is filtered while the remaining four-fifths continues to the efferent arteriole and peritubular capillaries. This ratio provides insight into the relative changes in GFR and renal blood flow under various physiological and pathological conditions.

<image>Panel A: Cross-sectional kidney view with cortex in light pink receiving thick red vessels labeled 90% of RBF. Panel B: Medulla in deeper red receiving thinner vessels labeled 10% of RBF, with graduated color intensity suggesting the osmotic gradient. Panel C: Circular inset showing relationship between RBF (1200 mL/min), RPF (660 mL/min), and GFR (125 mL/min) with filtration fraction (FF = 20%). Panel D: Calculations showing RPF = RBF × (1-Hct) and FF = GFR/RPF with labeled structures.</image>

Starling Forces and Determinants of GFR

Glomerular filtration is governed by the same Starling forces that regulate fluid movement across all capillary beds, though several unique features of the glomerulus favor unusually high filtration rates. The GFR is determined by the product of the filtration coefficient (Kf) and the net filtration pressure, expressed mathematically as GFR equals Kf multiplied by the quantity (PGC minus PBS) minus (πGC minus πBS).

The four Starling pressures determine the driving force for filtration. The glomerular capillary hydrostatic pressure (PGC) averages approximately 60 mmHg and represents the primary force favoring filtration. This pressure is remarkably high compared to other capillary beds, maintained by the unique arrangement of two arteriolar resistances in series. The hydrostatic pressure in Bowman's space (PBS) averages about 18 mmHg and opposes filtration by pushing back against the filtered fluid. The glomerular capillary oncotic pressure (πGC) averages approximately 32 mmHg at the afferent end but increases along the capillary length as protein-free filtrate is removed, concentrating plasma proteins. This oncotic pressure opposes filtration by drawing water back into the capillary. The oncotic pressure in Bowman's space (πBS) is essentially zero under normal conditions because the healthy filtration barrier excludes plasma proteins.

Calculating the net filtration pressure yields: 60 minus 18 minus 32 plus 0 equals 10 mmHg. This positive net filtration pressure drives fluid from the glomerular capillaries into Bowman's space. Unlike most systemic capillaries where filtration occurs at the arteriolar end and absorption at the venular end, the glomerular capillaries maintain positive filtration pressure along their entire length under normal conditions.

The filtration coefficient (Kf) represents the product of the hydraulic conductivity and the surface area available for filtration. The glomerular capillaries have exceptionally high hydraulic conductivity due to their fenestrated endothelium, and the total surface area is substantial given the parallel arrangement of approximately 20 to 40 capillary loops per glomerulus. Mesangial cell contraction reduces the available surface area and therefore decreases Kf. Various forms of glomerular disease can reduce Kf by decreasing either hydraulic conductivity or filtration surface area.

<image>Panel A: Cross-section of glomerular capillary loop with Bowman's space surrounding it, showing large red arrow pointing outward (PGC = 60 mmHg, favors filtration). Panel B: Smaller blue arrow pointing into capillary from Bowman's space (PBS = 18 mmHg, opposes) and green arrow representing oncotic pressure (πGC = 32 mmHg, opposes), with πBS = 0 indicated. Panel C: Calculation box showing Net Filtration Pressure = 60 - 18 - 32 + 0 = 10 mmHg. Panel D: Gradient color bar showing gradual increase in πGC along capillary length from afferent to efferent end.</image>

Factors Affecting GFR

Multiple physiological and pathological conditions alter GFR by modifying the Starling forces or the filtration coefficient. An increase in glomerular capillary hydrostatic pressure (PGC) elevates GFR, while increased oncotic pressure (πGC) or Bowman's space pressure (PBS) reduces GFR. Hypoalbuminemia transiently increases GFR by reducing the oncotic opposition to filtration, while dehydration and hemoconcentration increase oncotic pressure and reduce GFR. Ureteral obstruction raises pressure in Bowman's space, progressively reducing and eventually eliminating filtration if obstruction persists.

The afferent and efferent arterioles exert distinct effects on PGC, renal blood flow, and GFR. Afferent arteriolar constriction reduces blood flow into the glomerulus, lowering PGC, RBF, and GFR simultaneously. Afferent dilation has the opposite effect, increasing all three parameters. Efferent arteriolar constriction creates a more nuanced response. Moderate efferent constriction increases PGC by raising resistance to outflow from the glomerulus, thereby increasing GFR. However, because the efferent arteriole is downstream, this constriction also reduces total renal blood flow. With severe efferent constriction, the reduction in renal blood flow becomes the dominant factor and GFR eventually falls despite elevated PGC.

These principles have important clinical applications. ACE inhibitors and angiotensin receptor blockers dilate the efferent arteriole preferentially, reducing PGC and therefore GFR. While this may cause an initial rise in serum creatinine, these medications protect the glomerulus from hyperfiltration injury in conditions such as diabetic nephropathy. NSAIDs block prostaglandin synthesis, eliminating the protective vasodilation of the afferent arteriole that maintains GFR during states of reduced renal perfusion. Administering NSAIDs to volume-depleted patients can precipitate acute kidney injury. Ureteral obstruction illustrates how elevated PBS reduces filtration, and bilateral obstruction or obstruction of a solitary kidney rapidly leads to renal failure.

<image>Panel A: Glomerulus showing afferent constriction with narrowed afferent arteriole, reduced blood flow arrows, and box listing ↓PGC, ↓RBF, ↓GFR. Panel B: Glomerulus showing efferent constriction with narrowed efferent arteriole, blood pooling in glomerulus, and box listing ↑PGC, ↓RBF, ↑GFR (moderate) or ↓GFR (severe). Panel C: Clinical examples showing NSAIDs causing relative afferent constriction and ACE inhibitors causing efferent dilation. Panel D: Directional blood flow arrows with red arteries and blue resistance indicators.</image>

Autoregulation of Renal Blood Flow and GFR

The kidneys possess intrinsic mechanisms that maintain relatively constant renal blood flow and GFR despite fluctuations in systemic arterial pressure. This autoregulation is effective over a mean arterial pressure range of approximately 80 to 180 mmHg. Below this range, RBF and GFR decline proportionally with blood pressure. Above this range, both parameters increase. Within the autoregulatory range, the kidneys adjust arteriolar resistance to maintain stable perfusion and filtration.

Two mechanisms account for renal autoregulation. The myogenic mechanism responds within seconds to changes in arterial pressure. When increased pressure stretches the afferent arteriolar wall, stretch-activated cation channels in vascular smooth muscle cells trigger membrane depolarization, calcium entry, and vasoconstriction. This increased afferent resistance opposes the pressure increase and maintains constant downstream flow. The response is rapid and intrinsic to the vascular smooth muscle.

Tubuloglomerular feedback operates over a longer time scale of minutes and involves communication between the tubule and the glomerulus via the juxtaglomerular apparatus. When GFR increases, more sodium chloride is delivered to the macula densa at the end of the thick ascending limb. The macula densa cells sense this increased chloride load through the NKCC2 transporter and release paracrine signals including ATP and adenosine. These mediators cause afferent arteriolar constriction, reducing GFR back toward normal. Conversely, reduced sodium chloride delivery triggers release of prostaglandins and nitric oxide, which dilate the afferent arteriole to restore GFR. This feedback loop ensures that each nephron's filtration rate matches its tubular reabsorptive capacity.

<image>Panel A: Autoregulation curve plotting RBF and GFR (y-axis) against mean arterial pressure (x-axis, 40-200 mmHg) showing flat plateaus from 80-180 mmHg with declining values below 80 and rising values above 180. Panel B: Myogenic mechanism showing afferent arteriole smooth muscle stretched by increased pressure then contracting to normalize flow (timing: seconds). Panel C: Tubuloglomerular feedback showing macula densa at TAL sensing increased NaCl delivery, signaling via ATP/adenosine to afferent arteriole causing constriction (timing: minutes). Panel D: Color-coded structures with blue for tubular elements and red/pink for vascular elements.</image>

Neural and Hormonal Regulation

Beyond intrinsic autoregulation, the kidneys are subject to neural and hormonal influences that modulate renal blood flow and GFR according to systemic needs. The sympathetic nervous system innervates both afferent and efferent arterioles as well as the juxtaglomerular cells. Alpha-1 adrenergic receptors on arteriolar smooth muscle mediate vasoconstriction, while beta-1 receptors on juxtaglomerular cells stimulate renin release. During mild sympathetic activation, autoregulatory mechanisms largely compensate and GFR remains stable. However, moderate to severe sympathetic activation, as occurs during hemorrhage or hypovolemic shock, causes significant renal vasoconstriction with reductions in both RBF and GFR as the body prioritizes blood flow to heart and brain.

The renin-angiotensin-aldosterone system represents the kidney's principal hormonal regulatory axis. Three stimuli trigger renin release from juxtaglomerular cells: decreased renal perfusion pressure sensed by the afferent arteriole, decreased sodium chloride delivery sensed by the macula densa, and sympathetic nervous system activation via beta-1 receptors. Renin cleaves angiotensinogen to angiotensin I, which is converted to angiotensin II by ACE, primarily in the pulmonary circulation. Angiotensin II constricts the efferent arteriole more than the afferent, thereby maintaining GFR even as renal blood flow decreases. Additionally, angiotensin II stimulates aldosterone release for sodium retention and ADH release for water conservation.

Several other hormones influence renal hemodynamics. Atrial natriuretic peptide, released in response to atrial distension, dilates both afferent and efferent arterioles, increasing GFR and promoting natriuresis. Prostaglandins PGE2 and PGI2 provide protective afferent arteriolar dilation, particularly important during volume depletion when angiotensin II and sympathetic tone are elevated. This explains why NSAIDs, which block prostaglandin synthesis, can precipitate acute kidney injury in volume-depleted patients. Endothelin is a potent vasoconstrictor, while nitric oxide provides tonic vasodilation. Low-dose dopamine produces renal vasodilation through D1 receptors, though clinical trials have not demonstrated benefit from "renal-dose" dopamine.

<image>Panel A: Kidney with afferent and efferent arterioles showing sympathetic nerves reaching arterioles (α1 = vasoconstriction) and JG cells (β1 = renin release). Panel B: RAAS cascade showing renin → angiotensin I → angiotensin II, with AII preferentially constricting efferent arteriole. Panel C: Prostaglandins from kidney dilating afferent arteriole with protective label; inset showing volume depletion state where RAAS and SNS activated but prostaglandins preserve GFR. Panel D: Inset showing NSAID administration blocking PG leading to acute kidney injury, with red arteries, blue veins, and purple hormonal pathways.</image>

The Clearance Concept

Clearance provides a powerful conceptual and practical framework for understanding how the kidney handles any given substance. Clearance is defined as the volume of plasma completely cleared of a substance per unit time. Mathematically, clearance (C) equals the product of urine concentration (U) and urine flow rate (V), divided by plasma concentration (P): C = (U × V) / P. The units are volume per time, typically milliliters per minute.

The clearance of a substance relates to GFR in predictable ways based on how that substance is handled by the nephron. If a substance is freely filtered but neither reabsorbed nor secreted, its clearance exactly equals GFR. If a substance is filtered and also undergoes net reabsorption, its clearance is less than GFR because some of the filtered substance returns to the blood rather than being excreted. If a substance is filtered and also undergoes net secretion, its clearance exceeds GFR because additional substance is added to the urine beyond what was filtered. A clearance of zero indicates complete reabsorption.

Consider examples along this spectrum. Inulin, a fructose polymer, is freely filtered, neither reabsorbed nor secreted, and not metabolized; its clearance equals GFR. Glucose is freely filtered but completely reabsorbed under normal conditions, so its clearance is zero. Creatinine is freely filtered with minimal secretion, making its clearance slightly exceed GFR. Para-aminohippuric acid (PAH) is freely filtered and nearly completely secreted by the proximal tubule, achieving almost complete extraction from plasma during a single pass through the kidney; its clearance approximates renal plasma flow. Urea is freely filtered but partially reabsorbed, giving it a clearance less than GFR.

<image>Panel A: Nephron schematic showing inulin (green) filtered only passing through unchanged with clearance = GFR, and glucose filtered and completely reabsorbed with clearance = 0 and reabsorption arrows pointing away from tubule. Panel B: PAH filtered and secreted with secretion arrows adding to tubular content and clearance = RPF; creatinine filtered with slight secretion and clearance slightly higher than GFR. Panel C: Clearance formula C = UV/P with legend showing distinct colors for each substance. Panel D: Relationship summary showing Clearance > GFR implies net secretion and Clearance < GFR implies net reabsorption.</image>

Measurement of GFR

Accurate measurement of GFR is fundamental to assessing kidney function. The gold standard method employs inulin clearance. Inulin satisfies all requirements for an ideal filtration marker: it is freely filtered without protein binding, not reabsorbed, not secreted, and not metabolized. Its clearance therefore equals GFR exactly. However, inulin is exogenous and requires continuous intravenous infusion with timed urine collections, making it impractical for routine clinical use.

Creatinine clearance offers a practical endogenous alternative. Creatinine is produced at a relatively constant rate from muscle creatine metabolism, freely filtered at the glomerulus, and not reabsorbed. However, approximately 10 to 15 percent of urinary creatinine comes from tubular secretion rather than filtration, causing creatinine clearance to slightly overestimate true GFR. Despite this limitation, creatinine clearance remains clinically useful, particularly for drug dosing. Measuring creatinine clearance requires a 24-hour urine collection, which introduces collection errors.

Estimated GFR (eGFR) equations provide convenient GFR assessment from a single serum creatinine measurement combined with demographic factors. The Cockcroft-Gault equation estimates creatinine clearance as (140 minus age) times weight in kilograms, divided by 72 times serum creatinine, multiplied by 0.85 for females. The CKD-EPI equation is now preferred for eGFR reporting, incorporating serum creatinine, age, and sex to estimate GFR more accurately across a wider range of kidney function. These equations assume stable creatinine production and steady-state conditions.

Cystatin C offers an alternative endogenous marker. Produced by all nucleated cells at a relatively constant rate, cystatin C is freely filtered and catabolized in the proximal tubule. Unlike creatinine, cystatin C levels are less influenced by muscle mass, making it useful in patients with extremes of body composition. Equations combining creatinine and cystatin C may provide more accurate GFR estimates in certain populations.

Normal GFR in young healthy adults approximates 120 to 130 mL/min/1.73m². GFR declines with age at approximately 1 mL/min per year after age 30 to 40. Chronic kidney disease is staged by GFR: stage 3 corresponds to GFR 30 to 59 mL/min/1.73m², and stage 5 (kidney failure) corresponds to GFR less than 15 mL/min/1.73m².

<image>Panel A: Inulin clearance setup with IV infusion, timed urine collection, blood draws labeled as gold standard for research use. Panel B: 24-hour urine collection container with creatinine equation CrCl = (Ucr × V)/Pcr, noting slight overestimation due to secretion for clinical measurement. Panel C: Blood tube with CKD-EPI equation and required variables (serum creatinine, age, sex) for convenient routine estimation; cystatin C noted as alternative marker for special populations. Panel D: Table showing CKD stages with corresponding GFR values.</image>

Measurement of Renal Plasma Flow

Para-aminohippuric acid clearance provides a measure of renal plasma flow based on the kidney's highly efficient extraction of this organic acid. PAH is freely filtered at the glomerulus, with approximately 20 percent of plasma PAH entering the urine via filtration. The remaining 80 percent in peritubular plasma is actively secreted by organic anion transporters in the proximal tubule. At low plasma concentrations that do not saturate the secretory mechanism, approximately 90 percent of PAH is extracted during a single pass through the kidney.

Because PAH extraction is not quite complete, PAH clearance measures effective renal plasma flow (ERPF) rather than true RPF. The relationship is: ERPF = (UPAH × V) / PPAH. To calculate true renal plasma flow, ERPF is divided by the extraction ratio: RPF = ERPF / 0.9. From RPF, renal blood flow can be calculated as RBF = RPF / (1 minus Hematocrit).

While PAH clearance accurately measures RPF for research purposes, it is rarely used clinically. Most clinical assessments rely on eGFR rather than RPF measurements. However, understanding PAH clearance reinforces important concepts about tubular secretion and the meaning of clearance values that exceed GFR.

<image>Panel A: Nephron with glomerulus filtering 20% of incoming PAH indicated by filtered fraction arrows. Panel B: Proximal tubule secreting remaining 80% of PAH with proportionally sized arrows showing contributions. Panel C: ERPF calculation formula and correction to true RPF (RPF = ERPF/0.9), with relationship between RPF and RBF (RBF = RPF/(1-Hct)). Panel D: Pie chart showing 90% extraction with 10% escaping extraction, using orange for PAH and blue for plasma components with labeled extraction ratio.</image>

Clinical Applications

Clinical assessment of kidney function relies primarily on serum creatinine and eGFR, each with important limitations. Serum creatinine is widely available and inexpensive, but its interpretation requires understanding of factors affecting production. Patients with greater muscle mass produce more creatinine and will have higher baseline levels despite normal GFR. Elderly patients and those with muscle wasting produce less creatinine, so a "normal" creatinine may mask significantly reduced GFR. Meat ingestion can transiently raise creatinine. Certain medications including trimethoprim and cimetidine inhibit creatinine secretion, raising serum levels without affecting true GFR.

Several clinical situations make creatinine particularly misleading. In acute kidney injury, serum creatinine rises only after GFR has already fallen substantially; it is a lagging indicator that does not reflect real-time kidney function. In cachectic patients with minimal muscle mass, serum creatinine may remain deceptively normal despite severe kidney disease. At extremes of body size, standard equations become less accurate. In these situations, measured creatinine clearance, cystatin C-based estimates, or direct GFR measurement may be warranted.

The filtration fraction changes in predictable patterns with various conditions. Efferent arteriolar constriction, as occurs with angiotensin II, increases filtration fraction because GFR is maintained while RBF decreases. Volume depletion similarly increases filtration fraction as the kidney attempts to maintain filtration despite reduced perfusion. Understanding these relationships helps predict how interventions will affect kidney function. For example, initiating an ACE inhibitor in a patient dependent on angiotensin II to maintain GFR (such as bilateral renal artery stenosis) can precipitate acute kidney injury.

<image>Panel A: Factors affecting serum creatinine (muscle mass, age, diet, medications) with arrows indicating direction of effect. Panel B: Situations when creatinine is misleading including AKI with lag time on timeline, muscle wasting, and extremes of body size. Panel C: eGFR staging table for CKD stages 1-5 with clinical implications. Panel D: Filtration fraction changes in different conditions (efferent constriction, volume depletion) and clinical examples (ACE inhibitor initiation, renal artery stenosis) with warning symbols for dangerous combinations.</image>

Summary

• GFR approximates 125 mL/min or 180 L/day, determined by Starling forces and the filtration coefficient
• Net filtration pressure equals PGC minus PBS minus πGC, normally about 10 mmHg
• Afferent arteriolar constriction reduces PGC, RBF, and GFR
• Efferent arteriolar constriction increases PGC, decreases RBF, and increases GFR at moderate levels
• Autoregulation maintains stable RBF and GFR over MAP 80 to 180 mmHg via myogenic and tubuloglomerular feedback mechanisms
• Clearance represents the plasma volume cleared of a substance per unit time; clearance equals GFR if a substance is only filtered
• Inulin clearance is the gold standard for GFR measurement but impractical clinically
• Creatinine clearance slightly overestimates GFR due to tubular secretion
• eGFR calculated from serum creatinine via CKD-EPI equation is preferred for routine clinical use
• PAH clearance measures effective renal plasma flow because PAH is filtered and secreted

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown